These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 15492994

  • 1. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
    Wappenschmidt B, Wardelmann E, Gehrig A, Schöndorf T, Maass N, Bonatz G, Gassel AM, Pietsch T, Mallmann P, Weber BH, Schmutzler RK.
    Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L, Bussaglia E, Rodrguez I, Gallardo A, Pons C, Irving JA, Prat J.
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M.
    Cancer Res; 2000 Dec 15; 60(24):7052-6. PubMed ID: 11156411
    [Abstract] [Full Text] [Related]

  • 6. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G, Peiró FM, Ortiz-Martínez F, Planelles M, Sánchez-Tejada L, Alenda C, Ceballos S, Sánchez-Payá J, Laforga JB.
    Hum Pathol; 2013 Feb 15; 44(2):218-25. PubMed ID: 22955108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
    An HJ, Lee YH, Cho NH, Shim JY, Kim JY, Lee C, Kim SJ.
    Histopathology; 2002 Nov 15; 41(5):437-45. PubMed ID: 12405911
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
    Prasad M, Wang H, Douglas W, Barakat RR, Ellenson LH.
    Gynecol Oncol; 2005 Jan 15; 96(1):25-31. PubMed ID: 15589576
    [Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, Muller CY.
    Clin Cancer Res; 1998 Nov 15; 4(11):2577-83. PubMed ID: 9829719
    [Abstract] [Full Text] [Related]

  • 13. Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.
    Palacios J, Catasús L, Moreno-Bueno G, Matias-Guiu X, Prat J, Gamallo C.
    Virchows Arch; 2001 May 15; 438(5):464-9. PubMed ID: 11407474
    [Abstract] [Full Text] [Related]

  • 14. beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
    Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suárez A, Armas A.
    Am J Pathol; 1999 Aug 15; 155(2):527-36. PubMed ID: 10433945
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y, Xiong YY, Zhou YF.
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep 15; 38(9):594-9. PubMed ID: 20079187
    [Abstract] [Full Text] [Related]

  • 17. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
    Stelloo E, Nout RA, Naves LC, Ter Haar NT, Creutzberg CL, Smit VT, Bosse T.
    Gynecol Oncol; 2014 May 15; 133(2):197-204. PubMed ID: 24556061
    [Abstract] [Full Text] [Related]

  • 18. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
    Bussaglia E, del Rio E, Matias-Guiu X, Prat J.
    Hum Pathol; 2000 Mar 15; 31(3):312-7. PubMed ID: 10746673
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP, van der Putten LJ, van Tilborg AA, Lurkin I, Zwarthoff EC, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Visscher DW, Dowdy SC, Massuger LF.
    Gynecol Oncol; 2015 May 15; 137(2):245-51. PubMed ID: 25773202
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.